{
    "clinical_study": {
        "@rank": "147941", 
        "arm_group": {
            "arm_group_label": "Active or inactive MJ with 0, 200, 400, or 800 mg CBD", 
            "arm_group_type": "Other", 
            "description": "Each subject in the study will be tested on eight days, each day receiving a different combination of active/inactive marijuana cigarette plus 0, 200, 400 or 800 mg of cannabidiol"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to assess the effects of oral cannabidiol (CBD; 0, 200, 400,\n      800 mg) on smoked marijuana's (0, 5.6% THC) subjective, reinforcing, cognitive, and\n      cardiovascular effects. This experiment is expected to reveal CBD's intrinsic effects when\n      combined with placebo marijuana, as well as its ability to modulate the behavioral effects\n      of active marijuana."
        }, 
        "brief_title": "Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Smoking, Marijuana", 
        "condition_browse": {
            "mesh_term": [
                "Marijuana Abuse", 
                "Marijuana Smoking", 
                "Smoking"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults between the ages of 18 and 50.\n\n          -  Current marijuana use: Minimum of four times per week, 0.5 joints per occasion during\n             the preceding 4 weeks.\n\n          -  Able to perform study procedures\n\n          -  Women practicing an effective form of birth control\n\n        Exclusion Criteria:\n\n          -  Female subjects who are currently pregnant or breastfeeding.\n\n          -  Current, repeated illicit drug use other than marijuana\n\n          -  Presence of significant medical illness\n\n          -  History of heart disease\n\n          -  Request for drug treatment\n\n          -  Current parole or probation\n\n          -  Recent history of significant violent behavior\n\n          -  Major psychiatric disorder"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01844687", 
            "org_study_id": "Study Number CBD-001"
        }, 
        "intervention": {
            "arm_group_label": "Active or inactive MJ with 0, 200, 400, or 800 mg CBD", 
            "intervention_name": "cannabidiol", 
            "intervention_type": "Drug", 
            "other_name": "cannabidiol is abbreviated CBD"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "reinforcement, good drug effect, high, mood, cannabidiol", 
        "lastchanged_date": "May 21, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Michelle Wolf", 
                    "phone": "859-257-1612"
                }, 
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40513"
                    }, 
                    "name": "University of Kentucky, Straus Behavioral Research Bldg., 515 Oldham Ct."
                }, 
                "investigator": {
                    "last_name": "Sharon Walsh, Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "wechsle@nyspi.columbia.edu", 
                    "last_name": "Bennett Wechsler, B.S.", 
                    "phone": "212-543-5175"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Marijuana Outpatient Lab 1051 Riverside Dr. Unit #120"
                }, 
                "investigator": {
                    "last_name": "Margaret Haney, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "huebnerk@musc.edu", 
                    "last_name": "Kristi Huebner, BS RN MPH", 
                    "phone": "843-792-1901"
                }, 
                "contact_backup": {
                    "email": "irkki@musc.edu", 
                    "last_name": "Kim Irk, B.S.", 
                    "phone": "843-792-1231."
                }, 
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29425"
                    }, 
                    "name": "Center for Drug and Alcohol Programs, Room 459 North, 67 President St."
                }, 
                "investigator": {
                    "last_name": "Robert Malcolm, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Laboratory Study of the Influence of Oral Cannabidiol on the Subjective, Reinforcing and Cardiovascular Effects of Smoked Marijuana", 
        "other_outcome": [
            {
                "description": "Participants rate the strength, liking, desire to take again, good drug effect and bad drug effect of smoked marijuana.", 
                "measure": "Marijuana Rating Form", 
                "safety_issue": "No", 
                "time_frame": "2 minutes"
            }, 
            {
                "description": "Participants rate the capsule strength, capsule liking, desire to take again, good drug effect and bad drug effect.", 
                "measure": "Cannabidiol Capsule Rating Form", 
                "safety_issue": "No", 
                "time_frame": "2 minutes"
            }, 
            {
                "description": "Visual analog scale used to assess subjective drug effects including physical symptoms and mood.", 
                "measure": "Mood Scale", 
                "safety_issue": "No", 
                "time_frame": "2 minutes"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "New York State Psychiatric Institute", 
                "last_name": "Margaret Haney, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Medical University of South Carolina", 
                "last_name": "Robert J Malcolm, M.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Kentucky", 
                "last_name": "Sharon Walsh, Ph.D.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cognitive tasks such as the Digit-Symbol Substitution Task, Continuous Performance Task and Digit Span Backwards", 
            "measure": "Cognitive Performance Battery", 
            "safety_issue": "No", 
            "time_frame": "10 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01844687"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Institute on Drug Abuse (NIDA)", 
            "investigator_full_name": "Steve Sparenborg", 
            "investigator_title": "Pharmacotherapy Clinical Trials Team Leader", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Steve Sparenborg", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}